SU-C-103-05: Automated Interstitial Brachytherapy Catheter Localization From Volumetric MR Data

2013 ◽  
Vol 40 (6Part2) ◽  
pp. 94-94
Author(s):  
G Pernelle ◽  
T Kapur ◽  
A Mehrtash ◽  
T Penzkofer ◽  
A Damato ◽  
...  
Keyword(s):  
Interstitial Brachytherapy ◽  
Catheter Localization

WE-G-17A-05: Real-Time Catheter Localization Using An Active MR Tracker for Interstitial Brachytherapy

2014 ◽  
Vol 41 (6Part30) ◽  
pp. 525-525
Author(s):  
W Wang ◽  
A Damato ◽  
T Penzkofer ◽  
L Pan ◽  
W Gilson ◽  
...  
Keyword(s):  
Real Time ◽  
Interstitial Brachytherapy ◽  
Catheter Localization

PO-0255 CT-guided high-dose interstitial brachytherapy vs. SBRT in hepatocellular carcinoma

2021 ◽  
Vol 158 ◽  
pp. S210
Author(s):  
F. Walter ◽  
A.S. Duque ◽  
H. Weingandt ◽  
J. Well ◽  
R. Shpani ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Interstitial Brachytherapy ◽  
High Dose ◽  
Ct Guided

scholarly journals Role of interstitial brachytherpy using template (mupit) in locally advanced carcinoma cervix

2016 ◽  
Author(s):  
Ashish Bhange ◽  
Abhishek Gulia ◽  
Anirudh Punnakal ◽  
Anil Kumar Anand ◽  
Anil Kumar Bansal ◽  
...  
Keyword(s):  
Local Control ◽  
Residual Disease ◽  
Locally Advanced ◽  
Concurrent Chemotherapy ◽  
Interstitial Brachytherapy ◽  
Carcinoma Cervix ◽  
Advanced Carcinoma ◽  
Needle Position ◽  
Grade 3

Introduction: Locally advanced carcinoma cervix includes stages IIB, IIIA, IIIB and IVA. Interstitial brachytherapy has the potential to deliver adequate dose to lateral parametrium and to vagina. Hence, it is preferable in cases with distorted anatomy, extensive (lower) vaginal wall involvement, bulky residual disease post EBRT and parametrium involvement upto lateral pelvic wall. Aim and Objective: To determine clinical outcome and complications (acute and chronic) in locally advanced carcinoma cervix, treated with interstitial brachytherapy using template (MUPIT - Martinez universal perineal interstitial template). Materials and Methods: This study is a retrospective analysis of 37 cases of locally advanced carcinoma cervix (stage IIB-2, IIIB-30, IVA-5), treated with EBRT (dose-median 45Gy/25#) ± concurrent chemotherapy (CCT) - Inj. Cisplatin/Inj Carboplatin, followed by interstitial brachytherapy using MUPIT from December 2009 to June 2015. Initial treatment with EBRT ± CCT was followed by intertstitial brachytherapy. Under spinal anaesthesia and epidural analgesia, MUPIT application was done. Straight and divergent needles (median 26, range 19-29) were inserted to cover parametrium adequately. Needle position was verified with planning CT scan and Brachytherapy planning was done. Dose was normalized to 5 mm box surface from outermost needle with optimization of dose to OAR (Bladder, Rectum and Sigmoid colon). Prescription dose –25Gy in 5#. Treatment was delivered by Microselectron HDR using Ir192 source. Treatment fractions were delivered twice daily with min 6 Hrs. gap in-between fractions. Results: The median duration of follow-up was 25 months. Local control was achieved in 28 patients with residual disease in 7 patients and local recurrence in 2 patients. 10 patients had acute lower GI toxicity {Grade1 (n=6), Grade 2 (n=4)}, 2 patients had acute Grade 1 bladder toxicity. 1 patient had grade 3 and 1 patient had grade 4 chronic bladder toxicity. Chronic rectal toxicity was seen in 10 patients {Grade 2 (n=4), Grade 3 (n=4), Grade 4 (n=2)}. Conclusion: Local control was achieved in 28/37 patients (75.6%) and overall survival rate of 81.1% at median follow up of 25 months in patients with locally advanced carcinoma cervix and unfavorable prognostic factors.

scholarly journals Use of transrectal ultrasound for high dose rate interstitial brachytherapy for patients of carcinoma of uterine cervix

2010 ◽  
Vol 21 (1) ◽  
pp. 12 ◽  
Author(s):  
Daya Nand Sharma ◽  
Goura Kisor Rath ◽  
Sanjay Thulkar ◽  
Sunesh Kumar ◽  
Vellaiyan Subramani ◽  
...  
Keyword(s):  
Dose Rate ◽  
Uterine Cervix ◽  
Transrectal Ultrasound ◽  
High Dose Rate ◽  
Interstitial Brachytherapy ◽  
High Dose

Long-term outcome for very high-risk prostate cancer treated primarily with a triple modality approach to include permanent interstitial brachytherapy

Brachytherapy ◽  
2012 ◽  
Vol 11 (4) ◽  
pp. 250-255 ◽  
Author(s):  
Nathan Bittner ◽  
Gregory S. Merrick ◽  
Wayne M. Butler ◽  
Robert W. Galbreath ◽  
Jonathan Lief ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
High Risk ◽  
Interstitial Brachytherapy ◽  
Term Outcome ◽  
Long Term Outcome ◽  
High Risk Prostate Cancer ◽  
Risk Prostate Cancer ◽  
Modality Approach ◽  
Very High

N28 HDR INTERSTITIAL BRACHYTHERAPY AS THE ORGAN PRESERVATION TREATMENT OF PENILE NEOPLASM

2010 ◽  
Vol 9 (6) ◽  
pp. 541-542
Author(s):  
M. Giglok ◽  
B. Bialas ◽  
M. Fijalkowski ◽  
B. Smolska-Ciszewska ◽  
S. Kellas-Slęczka ◽  
...  
Keyword(s):  
Organ Preservation ◽  
Interstitial Brachytherapy ◽  
Penile Neoplasm

Monte Carlo dosimetry of high dose rate gynecologic interstitial brachytherapy

2013 ◽  
Vol 109 (3) ◽  
pp. 425-429 ◽  
Author(s):  
Maxime Desbiens ◽  
Michel D’Amours ◽  
Hossein Afsharpour ◽  
Frank Verhaegen ◽  
Marie-Claude Lavallée ◽  
...  
Keyword(s):  
Monte Carlo ◽  
Dose Rate ◽  
High Dose Rate ◽  
Interstitial Brachytherapy ◽  
High Dose

PO-1136: Combined intracavitary and interstitial brachytherapy in locally advanced cervical cancer.

2020 ◽  
Vol 152 ◽  
pp. S599
Author(s):  
F. Piccolo ◽  
B. Pappalardi ◽  
M. Carrara ◽  
C. Tenconi ◽  
T. Giandini ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Locally Advanced ◽  
Interstitial Brachytherapy ◽  
Advanced Cervical Cancer ◽  
Locally Advanced Cervical Cancer
Sign in / Sign up

Export Citation Format

Share Document